S&P 500 7,676.77 +0.70%
Nasdaq 26,169.38 +0.82%
S&P/TSX 35,944.16 +0.44%
Apple 343.91 −1.10%
Nvidia 216.00 +2.39%
Microsoft 532.60 +1.54%
Shopify 235.93 −0.13%
Royal Bank 284.26 +0.88%
CAD/USD 0.7133 −0.12%
AFTER HRS · 16:15 ET
Market ClerkRecap
Mon Oct 26 · after hours1 signal today94 insider buys this week · $48.3MCIRO short report next: Oct 31The week ahead
MM
INSIDER · CUE · Cue Biopharma, Inc. · VP, PRIN. ACCOUNTING OFFICER

Meluzio Michael Vincent

Every open-market transaction filed under this name, Oct 12 to Oct 12.

Filings
1
0 buys · 1 sell
Bought
—
open market, at cost
Sold
$32K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 12CUECue Biopharma, Inc.VP, Prin. Accounting OfficerSell1,144$28.05$32K−42.7%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.